Recovery is straightforward: resuming your injection on the original schedule allows semaglutide levels to rebuild within 23 weeks, and appetite suppression typically returns to previous levels
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is an FDA-approved GLP-1 receptor agonist used to treat type 2 diabetes and manage chronic weight in adults with obesity
The glutathione S-transferases: an update
More importantly, patients are KEEPING the weight off
An older GLP-1 drug called Saxenda was approved for kids ages 12 and up in 2014
Citraro R, Leo A, Marra R et al (2015) Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats